Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lixisenatide versus insulin glulisine for renal physiology in basal insulin-treated type 2 diabetes
NL-OMON42165Phase 4Active, not recruiting
- Sponsor
- Diabetes Centrum
- Start
- Sep 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in type 2 diabetes mellitus (T2DM) comparing Lixisenatide arm with Insulin glulisine arm (2 arms). Primary endpoints: Glomerular filtration rate, Effective renal plasma flow and 1 more. Started Sep 2014; status: active, not recruiting.
02
Drugs
lixisenatideinsulin glulisine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON42165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42165.